Metronomics: Intrinsic Anakoinosis Modulator?

Metronomics: Intrinsic Anakoinosis Modulator?

Bibliographic Details
Main Authors:	André Nicolas, Manon Carré, Eddy Pasquier
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-06-01
Series:	Frontiers in Pharmacology
Subjects:	anakoinosis metronomic chemotherapy drug repositioning biology of system chaos
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2018.00689/full

Similar Items

Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis
by: Daniel Heudobler, et al.
Published: (2018-11-01)

A Computational Model of Tumor Growth and Anakoinosis
by: Pan Pantziarka, et al.
Published: (2019-03-01)

Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis)
by: Albrecht Reichle, et al.
Published: (2020-09-01)

Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial
by: Arnauld Verschuur, et al.
Published: (2018-09-01)

Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue—Going Beyond Apoptosis Induction
by: Daniel Heudobler, et al.
Published: (2019-12-01)

Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease
by: Florian Lüke, et al.
Published: (2021-06-01)

Metronomic therapy for gynecologic cancers
by: Wen-Hsiang Su, et al.
Published: (2012-06-01)

Metronomic Chemotherapy
by: Marina Elena Cazzaniga, et al.
Published: (2021-05-01)

Metronomic chemotherapy regimens in oncology
by: M. Yu. Fedyanin, et al.
Published: (2016-04-01)

Durable control of metastatic nasopharyngeal carcinoma with metronomic chemotherapy
by: Po-Hsiang Huang, et al.
Published: (2017-03-01)

Oral etoposide and cyclophosphamide: A low-cost palliative metronomic chemotherapy in advanced pediatric cancers
by: Kiran Kumar, et al.
Published: (2020-01-01)

Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch
by: Prabhat Singh Malik, et al.
Published: (2014-04-01)

Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer
by: Maryna Bondarenko, et al.
Published: (2021-05-01)

Metronomic Chemotherapy - A New Path to Treat Advanced Non-small Cell Lung Cancer
by: Shuang ZHANG, et al.
Published: (2015-04-01)

Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
by: Daniel Heudobler, et al.
Published: (2021-10-01)

Metronomic palliative chemotherapy in maxillary sinus tumor
by: Vijay M Patil, et al.
Published: (2016-01-01)

Sustained Complete Response to Metronomic Chemotherapy in a Child with Refractory Atypical Teratoid Rhabdoid Tumor: A Case Report
by: Mahe Berland, et al.
Published: (2017-11-01)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
by: Do Young Kim
Published: (2017-06-01)

Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma
by: Rong-Sheng Qin, et al.
Published: (2018-10-01)

Metronomic Chemotherapy Combined with Dendritic Cell Vaccine  Inhibits VEGF Secretion
by: Yan ZHOU, et al.
Published: (2013-09-01)

Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms
by: Salvatore Tafuto, et al.
Published: (2019-08-01)

Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non‐Hodgkin lymphoma
by: Ke Wu, et al.
Published: (2019-08-01)

Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy
by: Roberto J. Arai, et al.
Published: (2018-06-01)

The Overall Efficacy and Outcomes of Metronomic Tegafur-Uracil Chemotherapy on Locally Advanced Head and Neck Squamous Cell Carcinoma: A Real-World Cohort Experience
by: Tsung-Jang Yeh, et al.
Published: (2021-02-01)

Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer
by: V. Petry, et al.
Published: (2015-05-01)

Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessments
by: Hiroyuki Suzuki, et al.
Published: (2021-11-01)

Efficacy and Toxicity of Metronomic Oral Vinorelbinen in Advanced Non-small Cell Lung Cancer after Failure to Multiple-lines Treatments
by: Shuyang YAO, et al.
Published: (2017-11-01)

Oral Metronomic Maintenance Therapy Can Improve Survival in High-Risk Neuroblastoma Patients Not Treated with ASCT or Anti-GD2 Antibodies
by: Xiaofei Sun, et al.
Published: (2021-07-01)

Metronomic therapy with oral 6-mercaptopurine in elderly acute myeloid leukemia: A prospective pilot study
by: Akhil Kapoor, et al.
Published: (2016-01-01)

Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy
by: Ruby Maharjan, et al.
Published: (2019-07-01)

Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage
by: Xiuwen Guan, et al.
Published: (2020-07-01)

Improvement of intratumor microdistribution of PEGylated liposome via tumor priming by metronomic S-1 dosing
by: Doi Y, et al.
Published: (2016-10-01)

Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?
by: Cazzaniga ME, et al.
Published: (2019-04-01)

Outcomes of advanced epithelial ovarian cancer with integration of metronomic chemotherapy: An Indian rural cancer centre experience
by: Avinash Pandey, et al.
Published: (2016-01-01)

Metronomic chemotherapy with tegafur-uracil following radical resection in stage II colorectal cancer
by: Tzu-Chun Chen, et al.
Published: (2021-05-01)

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer
by: Min Shi, et al.
Published: (2020-03-01)

An audit of the results of a triplet metronomic chemotherapy regimen incorporating a tyrosine kinase inhibitor in recurrent/metastatic head and neck cancers patients
by: Vijay M Patil, et al.
Published: (2016-01-01)

A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung)
by: Daniel Heudobler, et al.
Published: (2021-03-01)

Immunotherapy Combined with Metronomic Dosing: An Effective Approach for the Treatment of NSCLC
by: Eleni Skavatsou, et al.
Published: (2021-04-01)

The novel roles of stromal fibroblasts in metronomic chemotherapy: Focusing on cancer stemness and immunity
by: Wen-Ying Liao, et al.
Published: (2017-12-01)